Ascendis Pharma A/S

CUSIP 04351PAD3NOTE 2.250% 4/0ASNDQ4 2025

Ascendis Pharma A/S — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

—

Max % of class reported

Institutional Holders

13F filers (latest quarter)

Schedule 13D (activist) & 13G (passive) 5%+ ownership filings

No 13D/13G filings on record yet

Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Boussard & Gavaudan Investment Management LLP	8.5K	$11.95M
2	Polar Capital Holdings PLC	5.00M	$7.10M
3	State Of Wisconsin Investment Board	3.00M	$4.25M
4	Loomis Sayles & Co L P	17.7K	$3.78M
5	Bank Of New York Mellon Corp	200.0K	$279.0K
6	Oddo Bhf Asset Management Sas	161	$229.5K
7	Bnp Paribas Asset Management Holding S.A.	2.00M	$2.8K